作者
Donata Medaglini, Ali M Harandi, Tom HM Ottenhoff, Claire-Anne Siegrist, VSV-EBOVAC Consortium, Selidji Todagbe Agnandji, Rafi Ahmed, Jenna Anderson, Floriane Auderset, Luisa Borgianni, Jessica Brosnahan, Annalisa Ciabattini, Olivier Engler, Marielle C Haks, Gray Heppner, Alice Gerlini, Peter Gottfried Kremsner, Stephen Leib, Thomas Monath, Francis Ndungu, Patricia Njuguna, Mark Page, Gianni Pozzi, Rino Rappuoli, Francesco Santoro
发表日期
2015/12/9
来源
Science translational medicine
卷号
7
期号
317
页码范围
317ps24-317ps24
出版商
American Association for the Advancement of Science
简介
With an emphasis on systems analyses, the VSV-EBOVAC project harnesses state-of-the-art technologies that illuminate mechanisms behind the observed immunogenicity and reactogenicity of the rVSV-ZEBOV vaccine and ensures that such information is shared among stakeholders.
学术搜索中的文章
D Medaglini, AM Harandi, THM Ottenhoff, CA Siegrist… - Science translational medicine, 2015